Status:

COMPLETED

Upper GI Outcomes Following EMR

Lead Sponsor:

Professor Michael Bourke

Conditions:

Adenoma, Villous

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to evaluate the long-term outcomes of Endoscopic Resection (ER) of superficial lesions of the Upper Gastrointestinal Tract(UGIT)

Detailed Description

Endoscopic resection (ER) of superficial lesions of the upper gastrointestinal tract is a safe and effective surgery-sparing modality in experienced hands. It is often curative of dysplastic lesions a...

Eligibility Criteria

Inclusion

  • UGIT lesion \> 10mm
  • Lesion limited to the mucosal and/or submucosal layer (T1 lesion)
  • Aged 18 years or older

Exclusion

  • Lesion less than 10mm
  • Gastric lesion involves the muscularis propria (T2 lesion) on other staging modalities such as endoscopic ultrasonography (EUS)
  • Aged younger than 18 years

Key Trial Info

Start Date :

August 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT02305290

Start Date

August 1 2014

End Date

September 1 2023

Last Update

March 27 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Westmead Endoscopy Unit

Westmead, New South Wales, Australia, 2145

Upper GI Outcomes Following EMR | DecenTrialz